Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06421675 |
| Title | Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma (EMBRACE) |
| Acronym | EMBRACE |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Ontario Clinical Oncology Group (OCOG) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |